1. Home
  2. RTO vs RDY Comparison

RTO vs RDY Comparison

Compare RTO & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RTO
  • RDY
  • Stock Information
  • Founded
  • RTO 1925
  • RDY 1984
  • Country
  • RTO United Kingdom
  • RDY India
  • Employees
  • RTO N/A
  • RDY N/A
  • Industry
  • RTO Business Services
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • RTO Consumer Discretionary
  • RDY Health Care
  • Exchange
  • RTO Nasdaq
  • RDY Nasdaq
  • Market Cap
  • RTO 12.0B
  • RDY 11.6B
  • IPO Year
  • RTO N/A
  • RDY N/A
  • Fundamental
  • Price
  • RTO $26.45
  • RDY $13.93
  • Analyst Decision
  • RTO Buy
  • RDY Strong Buy
  • Analyst Count
  • RTO 1
  • RDY 1
  • Target Price
  • RTO N/A
  • RDY $16.90
  • AVG Volume (30 Days)
  • RTO 958.5K
  • RDY 1.2M
  • Earning Date
  • RTO 07-31-2025
  • RDY 10-24-2025
  • Dividend Yield
  • RTO 1.93%
  • RDY 0.51%
  • EPS Growth
  • RTO N/A
  • RDY 9.95
  • EPS
  • RTO 0.13
  • RDY 0.79
  • Revenue
  • RTO $7,581,860,530.00
  • RDY $3,851,623,984.00
  • Revenue This Year
  • RTO $45.27
  • RDY $6.29
  • Revenue Next Year
  • RTO $3.22
  • RDY $2.61
  • P/E Ratio
  • RTO $39.47
  • RDY $17.71
  • Revenue Growth
  • RTO N/A
  • RDY 14.10
  • 52 Week Low
  • RTO $19.60
  • RDY $12.26
  • 52 Week High
  • RTO $30.10
  • RDY $16.17
  • Technical
  • Relative Strength Index (RSI)
  • RTO 42.86
  • RDY 50.51
  • Support Level
  • RTO $26.46
  • RDY $13.79
  • Resistance Level
  • RTO $27.53
  • RDY $14.02
  • Average True Range (ATR)
  • RTO 0.45
  • RDY 0.22
  • MACD
  • RTO -0.25
  • RDY 0.04
  • Stochastic Oscillator
  • RTO 8.63
  • RDY 52.81

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: